TAK — Takeda Pharmaceutical Co News Story

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapNeutral

Market Cap
$41.22bn
Enterprise Value
$69.15bn
Revenue
¥4tn

All News

REG-Millennium Partners, L.P. Form 8.3 - Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical CoAnnouncement

07/01/2019 14:50

Form 8.3 - Takeda Pharmaceutical Company Limited

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:		Millennium International Management LP
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree		Takeda Pharmaceutical Company Limited
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure		4^th January 2019
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”		Yes, Shire plc

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:	Ordinary (JP3463000004) - interest held via holding of ADS and ADS Option (US8740602052)
	Interests		Short positions
	Number	%	Number	%
(1) Relevant securities owned and/or controlled:	1,562,743	0.199%	11,106,682	1.416%
(2) Cash-settled derivatives:	1,633,297	0.208%	959,673	0.122%
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:	250,000	0.032%	0	0.000%
TOTAL:	3,446,040	0.439%	12,066,355	1.539%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security	Purchase/sale	Number of securities	Price per unit (USD)
US8740602052	Sale	14	17.36
US8740602052	Sale	1,100	17.49
US8740602052	Purchase	68	17.07
US8740602052	Purchase	100	17.09
US8740602052	Purchase	1,636	17.10
US8740602052	Purchase	200	17.11
US8740602052	Purchase	100	17.12
US8740602052	Purchase	478	17.13
US8740602052	Purchase	810	17.14
US8740602052	Purchase	2,050	17.15
US8740602052	Purchase	953	17.16
US8740602052	Purchase	1,474	17.17
US8740602052	Purchase	2,100	17.18
US8740602052	Purchase	2,103	17.19
US8740602052	Purchase	3,700	17.20
US8740602052	Purchase	458	17.21
US8740602052	Purchase	300	17.22
US8740602052	Purchase	297	17.24
US8740602052	Purchase	3	17.25
US8740602052	Purchase	325	17.26
US8740602052	Purchase	225	17.27
US8740602052	Purchase	925	17.28
US8740602052	Purchase	300	17.29
US8740602052	Purchase	896	17.30
US8740602052	Purchase	1,504	17.32
US8740602052	Purchase	300	17.33
US8740602052	Purchase	2,794	17.34
US8740602052	Purchase	1,500	17.35
US8740602052	Purchase	1,000	17.36
US8740602052	Purchase	400	17.37
US8740602052	Purchase	606	17.38
US8740602052	Purchase	600	17.39
US8740602052	Purchase	100	17.41
US8740602052	Purchase	715	17.43
US8740602052	Purchase	300	17.44
US8740602052	Purchase	600	17.46
US8740602052	Purchase	125	17.47
US8740602052	Purchase	125	17.48
US8740602052	Purchase	1,100	17.49
US8740602052	Purchase	200	17.50
US8740602052	Purchase	40	17.54
US8740602052	Purchase	1,011	17.55
US8740602052	Purchase	391	17.58
US8740602052	Purchase	1,553	17.61
US8740602052	Purchase	1,758	17.62
US8740602052	Purchase	2,050	17.63
US8740602052	Purchase	7,553	17.64
US8740602052	Purchase	3,725	17.65
US8740602052	Purchase	8,135	17.66
US8740602052	Purchase	6,300	17.67
US8740602052	Purchase	3,662	17.68
US8740602052	Purchase	4,315	17.69
US8740602052	Purchase	1,491	17.70
US8740602052	Purchase	5,453	17.71
US8740602052	Purchase	9,407	17.72
US8740602052	Purchase	10,130	17.73
US8740602052	Purchase	3,758	17.74
US8740602052	Purchase	4,213	17.75
US8740602052	Purchase	953	17.76
US8740602052	Purchase	600	17.77
US8740602052	Purchase	1,500	17.78
US8740602052	Purchase	500	17.79
US8740602052	Purchase	100	17.80
US8740602052	Purchase	225	17.81
US8740602052	Purchase	625	17.82
US8740602052	Purchase	499	17.83
US8740602052	Purchase	200	17.84
US8740602052	Purchase	300	17.85
US8740602052	Purchase	25	17.86
US8740602052	Purchase	100	17.88
US8740602052	Purchase	25	17.91
US8740602052	Purchase	100	17.99
US8740602052	Sale	100	17.05
US8740602052	Sale	100	17.06
US8740602052	Sale	200	17.08
US8740602052	Sale	400	17.09
US8740602052	Sale	401	17.10
US8740602052	Sale	300	17.11
US8740602052	Sale	700	17.12
US8740602052	Sale	300	17.13
US8740602052	Sale	200	17.14
US8740602052	Sale	200	17.15
US8740602052	Sale	578	17.16
US8740602052	Sale	400	17.18
US8740602052	Sale	325	17.19
US8740602052	Sale	100	17.20
US8740602052	Sale	100	17.22
US8740602052	Sale	300	17.24
US8740602052	Sale	200	17.26
US8740602052	Sale	100	17.27
US8740602052	Sale	200	17.28
US8740602052	Sale	200	17.29
US8740602052	Sale	200	17.31
US8740602052	Sale	100	17.33
US8740602052	Sale	100	17.34
US8740602052	Sale	300	17.38
US8740602052	Sale	200	17.39
US8740602052	Sale	100	17.42
US8740602052	Sale	200	17.43
US8740602052	Sale	900	17.44
US8740602052	Sale	200	17.45
US8740602052	Sale	200	17.46
US8740602052	Sale	100	17.48
US8740602052	Sale	100	17.50
US8740602052	Sale	100	17.52
US8740602052	Sale	200	17.58
US8740602052	Sale	100	17.59
US8740602052	Sale	200	17.60
US8740602052	Sale	840	17.62
US8740602052	Sale	697	17.63
US8740602052	Sale	136	17.64
US8740602052	Sale	101	17.65
US8740602052	Sale	520	17.66
US8740602052	Sale	200	17.67
US8740602052	Sale	100	17.68
US8740602052	Sale	301	17.69
US8740602052	Sale	1,253	17.70
US8740602052	Sale	865	17.71
US8740602052	Sale	1,208	17.72
US8740602052	Sale	200	17.73
US8740602052	Sale	771	17.74
US8740602052	Sale	528	17.75
US8740602052	Sale	553	17.76
US8740602052	Sale	127	17.78
US8740602052	Sale	200	17.79
US8740602052	Sale	6	17.80
US8740602052	Sale	200	17.82
US8740602052	Sale	100	17.88
US8740602052	Sale	400	17.90

Class of relevant security	Purchase/sale	Number of securities	Price per unit (JPY)
JP3463000004	Purchase	100	3,600.00
JP3463000004	Purchase	100	3,620.00
JP3463000004	Purchase	200	3,648.00
JP3463000004	Purchase	11,800	3,654.76
JP3463000004	Purchase	90,600	3,654.94
JP3463000004	Purchase	216,100	3,654.96
JP3463000004	Purchase	6,700	3,661.44
JP3463000004	Purchase	3,100	3,666.10
JP3463000004	Purchase	200	3,669.50
JP3463000004	Purchase	12,600	3,672.44
JP3463000004	Purchase	1,800	3,674.67
JP3463000004	Purchase	700	3,679.57
JP3463000004	Purchase	600	3,681.00
JP3463000004	Purchase	5,500	3,681.56
JP3463000004	Purchase	400	3,682.00
JP3463000004	Purchase	400	3,684.00
JP3463000004	Purchase	600	3,685.00
JP3463000004	Purchase	2,100	3,686.00
JP3463000004	Purchase	1,400	3,687.00
JP3463000004	Purchase	2,100	3,687.52
JP3463000004	Purchase	1,800	3,688.00
JP3463000004	Purchase	900	3,688.33
JP3463000004	Purchase	1,200	3,689.00
JP3463000004	Purchase	700	3,690.00
JP3463000004	Purchase	1,000	3,691.00
JP3463000004	Purchase	200	3,691.50
JP3463000004	Purchase	1,000	3,692.00
JP3463000004	Purchase	400	3,692.38
JP3463000004	Purchase	200	3,692.50
JP3463000004	Purchase	800	3,693.00
JP3463000004	Purchase	700	3,694.00
JP3463000004	Purchase	700	3,695.00
JP3463000004	Purchase	700	3,696.00
JP3463000004	Purchase	1,900	3,696.34
JP3463000004	Purchase	300	3,697.00
JP3463000004	Purchase	8,600	3,697.70
JP3463000004	Purchase	200	3,698.00
JP3463000004	Purchase	41,800	3,698.01
JP3463000004	Purchase	103,600	3,698.06
JP3463000004	Purchase	5,700	3,698.93
JP3463000004	Purchase	300	3,699.00
JP3463000004	Purchase	200	3,699.50
JP3463000004	Purchase	1,600	3,700.00
JP3463000004	Purchase	600	3,700.33
JP3463000004	Purchase	3,300	3,700.39
JP3463000004	Purchase	2,900	3,701.03
JP3463000004	Purchase	2,600	3,701.73
JP3463000004	Purchase	300	3,704.00
JP3463000004	Purchase	500	3,710.40
JP3463000004	Purchase	700	3,711.00
JP3463000004	Purchase	1,600	3,711.93
JP3463000004	Purchase	200	3,713.75
JP3463000004	Purchase	400	3,714.00
JP3463000004	Purchase	10,900	3,715.62
JP3463000004	Purchase	1,200	3,716.00
JP3463000004	Purchase	204,700	3,716.32
JP3463000004	Purchase	83,600	3,716.47
JP3463000004	Purchase	5,300	3,716.77
JP3463000004	Purchase	17,200	3,717.11
JP3463000004	Purchase	600	3,717.50
JP3463000004	Purchase	2,100	3,717.67
JP3463000004	Purchase	200	3,718.00
JP3463000004	Purchase	19,000	3,718.36
JP3463000004	Purchase	45,200	3,718.82
JP3463000004	Purchase	2,500	3,719.16
JP3463000004	Purchase	500	3,720.40
JP3463000004	Purchase	400	3,721.00
JP3463000004	Purchase	100	3,721.90
JP3463000004	Purchase	400	3,722.00
JP3463000004	Purchase	100	3,725.00
JP3463000004	Purchase	300	3,727.00
JP3463000004	Purchase	400	3,734.00
JP3463000004	Purchase	2,200	3,735.00
JP3463000004	Purchase	800	3,736.00
JP3463000004	Purchase	2,200	3,737.00
JP3463000004	Purchase	1,000	3,737.90
JP3463000004	Purchase	100	3,738.00
JP3463000004	Purchase	500	3,739.00
JP3463000004	Purchase	100	3,739.90
JP3463000004	Purchase	1,300	3,740.00
JP3463000004	Purchase	1,100	3,741.00
JP3463000004	Purchase	1,000	3,742.00
JP3463000004	Purchase	400	3,743.00
JP3463000004	Purchase	600	3,744.00
JP3463000004	Purchase	1,400	3,750.00
JP3463000004	Purchase	500	3,750.60
JP3463000004	Purchase	3,900	3,750.67
JP3463000004	Purchase	72,000	3,750.93
JP3463000004	Purchase	31,200	3,751.14
JP3463000004	Purchase	200	3,751.50
JP3463000004	Purchase	5,400	3,751.76
JP3463000004	Purchase	300	3,753.00
JP3463000004	Purchase	104,600	3,754.16
JP3463000004	Purchase	800	3,754.50
JP3463000004	Purchase	44,500	3,754.60
JP3463000004	Purchase	5,600	3,754.98
JP3463000004	Purchase	7,100	3,755.34
JP3463000004	Purchase	800	3,755.38
JP3463000004	Purchase	1,600	3,756.00
JP3463000004	Purchase	5,000	3,756.70
JP3463000004	Purchase	200	3,757.00
JP3463000004	Purchase	1,000	3,757.18
JP3463000004	Purchase	200	3,759.50
JP3463000004	Purchase	900	3,764.33
JP3463000004	Sale	400	3,662.25
JP3463000004	Sale	1,100	3,663.05
JP3463000004	Sale	9,200	3,663.48
JP3463000004	Sale	2,100	3,702.00
JP3463000004	Sale	2,900	3,703.00
JP3463000004	Sale	5,000	3,705.00
JP3463000004	Sale	10,000	3,707.00
JP3463000004	Purchase	300	3,626.00

(b) Cash-settled derivative transactions

Class of relevant security	Product description e.g. CFD	Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position	Number of reference securities	Price per unit
JP3463000004	CFD	Increasing a short position	1,500	3,701.53 JPY
JP3463000004	CFD	Increasing a short position	1,000	34.72 USD
JP3463000004	CFD	Increasing a long position	5,700	3,627.11 JPY
JP3463000004	CFD	Increasing a long position	238,000	3,713.47 JPY
JP3463000004	CFD	Increasing a long position	25,400	3,697.99 JPY

Class of relevant security	Product description e.g. CFD	Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position	Number of reference securities	Price per unit (USD)
US8740602052	CFD	Increasing a long position	58,411	17.10
US8740602052	CFD	Increasing a long position	50,000	17.10
US8740602052	CFD	Increasing a long position	15,000	17.45

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

NONE

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

NONE

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

YES

Date of disclosure:		7^th January 2019
Contact name:		Milos Naumovic
Telephone number:		+44 203 650 8203

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

SUPPLEMENTAL FORM 8 (OPEN POSITIONS)

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the “Code”)

1. KEY INFORMATION

Full name of person making disclosure:		Millennium International Management LP
Name of offeror/offeree in relation to whose relevant securities the disclosure relates:		Takeda Pharmaceutical Company Limited

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class of relevant security

Product description e.g. call option

Written or purchased

Number of securities to which option or derivative relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

US8740602052

Call Option

Purchased

250,000

4,200 JPY

American

20190308

3. AGREEMENTS TO PURCHASE OR SELL ETC.

Full details should be given so that the nature of the interest or position can be fully understood:

It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk

View source version on businesswire.com: https://www.businesswire.com/news/home/20190107005671/en/

Millennium Partners, L.P.

TAK — Takeda Pharmaceutical Co News Story

REG-Millennium Partners, L.P. Form 8.3 - Takeda Pharmaceutical Company Limited

Recent news on Takeda Pharmaceutical Co

REG - Malin Corp PLC - Malin Announces 2021 Full Year Results

REG - Takeda Pharma.Co.Ltd Shire plc - Confirmation of post-offer intention statements

REG - Morgan Stanley&CoLLC Takeda Pharma.Co.Ltd - Form 8.5 (EPT/RI) - Replacement of Takeda

REG - Takeda Pharma.Co.Ltd Shire plc - Statement re Applicable Exchange Rate

REG - Morgan Stanley Takeda Pharma.Co.Ltd - Form 8.5 (EPT/NON-RI) - Replacement of Takeda